-
Products
-
- Featured Products
- Supraflex Cruz
-
- Professionals
- Patients & Caregivers
- Investors
- About SMT
DISCLAIMER – IMPORTANT
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.
The following disclaimer applies to the Draft Red Herring Prospectus of Sahajanand Medical Technologies Limited (the “Company”) dated July 25, 2025 (“DRHP”) filed with the Securities and Exchange Board of India (the “SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) and hosted on this website in connection with the initial public offering of equity shares of face value ₹1 each of the Company (“Equity Shares” and such initial public offering as the “Offer”).
The DRHP has been made available on this website in electronic form solely to comply with Regulation 26 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the DRHP. By accessing the DRHP, you agree to follow and be bound by the following terms and conditions, including any modifications to them from time to time. You should read the DRHP and seek professional advice before taking any action
The DRHP is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the DRHP, is not intended for, and may not be accessed in or by, or distributed or transmitted in, into or to, directly or indirectly, the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”) or any other jurisdiction where it is unlawful to do so. All persons residing outside of the United States who wish to access the DRHP contained on the following page of this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website or require registration or approval for any acquisition of securities by them. No part of the contents of the DRHP shall be copied or duplicated in any form by any means or redistributed. The DRHP does not amount to, or is intended to be, a prospectus or an offer document, in terms of the Companies Act, 2013, and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and nothing in the DRHP constitutes an offer or an invitation by or on behalf of either the Company or any of the members of the Syndicate (as defined in the DRHP) to subscribe for or purchase any of the securities described therein.
The DRHP does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The securities offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. Accordingly, the securities are only being offered and sold outside the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur.
The Company, and Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited (collectively, the “Book Running Lead Managers”) and their respective affiliates, directors, officers, agents, representatives, advisers and employees do not accept any liability whatsoever, direct or indirect, that may arise from the use of the information contained on this website. The information in the DRHP is as of the date thereof and neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees are under any obligation to update or revise the DRHP to reflect circumstances arising after the date thereof. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company, the Book Running Lead Managers nor any of their respective affiliates, directors, officers, agents, representatives, advisers or employees accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of the DRHP in electronic format.
Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, see the section titled “Risk Factors” in the red herring prospectus which will be available when filed with the Registrar of Companies, Registrar of Companies, Gujarat at Ahmedabad (“RoC”) and SEBI in the future. Any decision on whether to invest in the equity shares described in the DRHP may only be made after a red herring prospectus has been filed with the RoC and must be made solely on the basis of the red herring prospectus proposed to be filed with the RoC. Potential investors should not rely on the DRHP filed with SEBI and the Stock Exchanges.
You are accessing this website at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses. The Company and the Book Running Lead Managers cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the DRHP beyond the date of the DRHP. Neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website, or by the use of this website or the DRHP. Neither the Company nor any of its affiliates or their respective directors, officers and employees will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
The information is current only as of its date and shall not, under any circumstances, create any implication that the information contained therein is correct as of any time subsequent to the date thereof or that there has been no change in the financial condition or affairs of the Company since such date. This document may be updated from time to time and there is no undertaking the Company or any of their affiliates to post any such amendments or supplements on this website.
Failure to comply with this disclaimer may result in a violation of the applicable laws of India and other jurisdictions. Any other information contained in, or that can be accessed via our website does not constitute a part of the DRHP.
IF YOU ARE NOT PERMITTED TO VIEW THE MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.
The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in any jurisdiction, including without limitation, India.
To access this information, you must confirm, by pressing on the button marked “I Confirm”, that at the time of access, you are located in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.
DISCLAIMER – IMPORTANT
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing. It applies to all persons who view this site.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (THE “SEBI ICDR REGULATIONS”).
The following disclaimer applies to the red herring prospectus dated October 9, 2026 (“RHP”) of Sahajanand Medical Technologies Limited (the “Company”) filed with the Registrar of Companies, Gujarat at Ahmedabad (“RoC”) and submitted to the Securities and Exchange Board of India (the “SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) and hosted on this website in connection with the initial public offering of equity shares of face value ₹1 each of the Company (“Equity Shares” and such initial public offering as the “Offer”).
The RHP has been made available on this website in electronic form solely to comply with Regulation 26 of the SEBI ICDR Regulations. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the RHP. By accessing the RHP, you agree to follow the following terms and conditions, including any modifications to them from time to time.
The RHP is directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the RHP, is not intended for, and may not be accessed in or by, or distributed or transmitted in, into or to, directly or indirectly, the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”) or any other jurisdiction where it is unlawful to do so. All persons residing outside of the United States who wish to access the RHP contained on the following page of this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website or require registration or approval for any acquisition of securities by them. No part of the contents of the RHP shall be copied or duplicated in any form by any means or redistributed. The information contained in the RHP may not be updated since its original publication date and may not reflect the latest updates, if any.
The RHP does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The securities offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933 (the “U.S. Securities Act”) and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. Accordingly, the securities are only being offered and sold outside the United States in offshore transactions as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur.
Any person into whose possession the RHP comes is required to inform himself or herself about and to observe any such restrictions. The Company, and Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited (collectively, the “Book Running Lead Managers”) and their respective affiliates, directors, officers, agents, representatives, advisers and employees do not accept any liability whatsoever, direct or indirect, that may arise from the use of the information contained on this website. The information in the RHP is as of the date thereof and neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees are under any obligation to update or revise the RHP to reflect circumstances arising after the date thereof. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company, the Book Running Lead Managers nor any of their respective affiliates, directors, officers, agents, representatives, advisers or employees accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of the RHP in electronic format.
Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, see the section titled “Risk Factors” in the RHP. Any decision on whether to invest in the equity shares must be made solely on the basis of the RHP. Potential investors should not rely on the draft red herring prospectus dated July 25, 2025 (“DRHP”) filed by the Company with SEBI and the Stock Exchanges.
Any person into whose possession the RHP comes is required to inform himself or herself about and to observe any such restrictions. Investors are advised not to rely on any other document, content or information provided on the Offer on the internet / online websites / social media platforms / micro-blogging platforms and by the influencers since the same is not approved/ commissioned/ paid by the Company or its directors / key managerial personnel in any manner. Investors are advised to rely only on the information contained in the RHP and the price band advertisement for making investment decision.
You are accessing this website at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses. Neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website, or by the use of this website or the RHP. Neither the Company nor any of its affiliates or their respective directors, officers and employees will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
Failure to comply with this disclaimer may result in a violation of the applicable laws of India and other jurisdictions. Any other information contained in, or that can be accessed via our website does not constitute a part of the RHP.
IF YOU ARE NOT PERMITTED TO VIEW THE MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.
The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in any jurisdiction, including without limitation, India.
To access this information, you must confirm, by pressing on the button marked “I Confirm”, that at the time of access, you are located in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.
DISCLAIMER – IMPORTANT
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED (THE “SEBI ICDR REGULATIONS”).
The following disclaimer applies to the abridged prospectus dated October 9, 2026 (the “Abridged Prospectus”) to the red herring prospectus dated October 9, 2026 (“RHP”) of Sahajanand Medical Technologies Limited (the “Company”) filed with the Registrar of Companies, Gujarat at Ahmedabad (“RoC”) and submitted to the Securities and Exchange Board of India (the “SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”), and hosted on this website in relation to the initial public offering of the equity shares of face value of ₹1 each (“Equity Shares”) of the Company (the “Offer”).
The Abridged Prospectus has been made available on this website in electronic form solely to comply with the SEBI ICDR Regulations. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Abridged Prospectus. By accessing the Abridged Prospectus, you agree to follow the following terms and conditions, including any modifications to them from time to time.
The Abridged Prospectus is directed at, and is intended for distribution to, and use by, residents of India only. You may not distribute a copy of the Abridged Prospectus to any person outside India. The information in this portion of our website, including the Abridged Prospectus, is not intended for, and may not be accessed in or by, or distributed or transmitted in, into or to, directly or indirectly, the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”) or any other jurisdiction where it is unlawful to do so. All persons residing outside of the United States who wish to access the Abridged Prospectus contained on the following page of this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website or require registration or approval for any acquisition of securities by them. No part of the contents of the Abridged Prospectus shall be copied or duplicated in any form by any means or redistributed.
The Abridged Prospectus does not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The Equity Shares in the Offer have not been and will not be registered under the United States Securities Act of 1933 (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold outside of the United States to investors in offshore transactions as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur. No public offering of the Equity Shares or other securities is being made in the United States.
No person outside India is eligible to Bid for Equity Shares in the Offer unless that person has received the preliminary offering memorandum for the Offer, which comprises the RHP and the preliminary international wrap (which contains, among other things, the selling restrictions for the Offer outside India).
The Company, and Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited (collectively, the “Book Running Lead Managers”) and their respective affiliates, directors, officers, agents, representatives, advisers and employees do not accept any liability whatsoever, direct or indirect, that may arise from the use of the information contained on this website. The information in the Abridged Prospectus is as of the date thereof and neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees are under any obligation to update or revise the Abridged Prospectus to reflect circumstances arising after the date thereof. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company, the Book Running Lead Managers nor any of their respective affiliates, directors, officers, agents, representatives, advisers or employees accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of the Abridged Prospectus in electronic format.
Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, see the section titled “Risk Factors” of the RHP. Any decision on whether to invest in the equity shares described in the Abridged Prospectus must be made solely on the basis of the RHP. As there may be material changes in the draft red herring prospectus dated July 25, 2025 (“DRHP”) filed with SEBI and the Stock Exchanges versus the RHP, potential investors should not rely on the DRHP.
Any person into whose possession the Abridged Prospectus comes is required to inform himself or herself about and to observe any such restrictions. Investors are advised not to rely on any other document, content or information provided on the Offer on the internet / online websites / social media platforms / micro-blogging platforms and by the influencers since the same is not approved/ commissioned/ paid by the Company or its directors / key managerial personnel in any manner. Investors are advised to rely only on the information contained in the RHP, the Abridged Prospectus and the price band advertisement for making investment decision.
You are accessing this website at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses. Neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, inability to access, any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website, or by use of this website or the Abridged Prospectus. Neither the Company nor any of its affiliates or their respective directors, officers and employees will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
Failure to comply with this disclaimer may result in a violation of the applicable laws of India and other jurisdictions. Any other information contained in, or that can be accessed via our website does not constitute a part of the Abridged Prospectus.
IF YOU ARE NOT PERMITTED TO VIEW THE MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.
The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India.
To access this information, you must confirm, by pressing on the button marked “I Confirm”, that at the time of access, you are located in India and have read the disclaimer set out above and you agree to be bound by its terms. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.
DISCLAIMER – IMPORTANT
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.
The following disclaimer applies to the Draft Red Herring Prospectus of Sahajanand Medical Technologies Limited (the “Company”) dated July 25, 2025 (“DRHP”) filed with the Securities and Exchange Board of India (the “SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) as well as the audio visual film of the Company (“IPO AV”), hosted on this website, in connection with the initial public offering of equity shares of face value ₹1 each of the Company (“Equity Shares” and such initial public offering as the “Offer”).
The DRHP has been made available on this website in electronic form solely to comply with Regulation 26 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the DRHP. The IPO AV is being made available on this website in accordance with SEBI master circular no. SEBI/HO/CFD/POD-1/P/CIR/2024/0154 dated November 11, 2024, issued by SEBI. By accessing the DRHP and/or the IPO AV, you agree to follow and be bound by the following terms and conditions, including any modifications to them from time to time. You should read the DRHP and seek professional advice before taking any action.
The DRHP and the IPO AV are directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the DRHP and the IPO AV, is not intended for, and may not be accessed in or by, or distributed or transmitted in, into or to, directly or indirectly, the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”) or any other jurisdiction where it is unlawful to do so. All persons residing outside of the United States who wish to access the DRHP and/or the IPO AV contained on the following page of this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website or require registration or approval for any acquisition of securities by them. No part of the contents of the DRHP and the IPO AV shall be copied or duplicated in any form by any means or redistributed. Neither the DRHP nor the IPO AV amount to, or is intended to be, a prospectus or an offer document, in terms of the Companies Act, 2013, and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and nothing in the DRHP or the IPO AV constitutes an offer or an invitation by or on behalf of either the Company or any of the members of the Syndicate (as defined in the DRHP) to subscribe for or purchase any of the securities described therein.
The DRHP and the IPO AV do not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The securities offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. Accordingly, the securities are only being offered and sold outside the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur.
The Company, and Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited (collectively, the “Book Running Lead Managers”) and their respective affiliates, directors, officers, agents, representatives, advisers and employees do not accept any liability whatsoever, direct or indirect, that may arise from the use of the information contained on this website. The information in the DRHP and the IPO AV is as of the date thereof and neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees are under any obligation to update or revise the DRHP and the IPO AV to reflect circumstances arising after the date thereof. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company, the Book Running Lead Managers nor any of their respective affiliates, directors, officers, agents, representatives, advisers or employees accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of the DRHP and the IPO AV in electronic format.
Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, see the section titled “Risk Factors” in the red herring prospectus which will be available when filed with the Registrar of Companies, Gujarat at Ahmedabad (“RoC”) and SEBI in the future. Any decision on whether to invest in the equity shares described in the DRHP and the IPO AV may only be made after a red herring prospectus has been filed with the RoC and must be made solely on the basis of the red herring prospectus proposed to be filed with the RoC. Potential investors should not rely on the DRHP filed with SEBI and the Stock Exchanges or on the IPO AV.
Any person into whose possession the Draft Red Herring Prospectus and the IPO AV comes is required to inform himself or herself about and to observe any restrictions. Investors are advised not to rely on any other document, content or information provided on the Offer on the internet / online websites/ social media platforms / micro-blogging platforms and by the influencers since the same is not approved/ commissioned/ paid by the Company or its promoter(s)/directors/KMPs in any manner. Investors are advised to rely only on the information contained in the Red Herring Prospectus and the price band advertisement for making investment decision.
You are accessing this website at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses. The Company and the Book Running Lead Managers cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the DRHP or the IPO AV beyond the date of the DRHP. Neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website, or by the use of this website, IPO AV or the DRHP. Neither the Company nor any of its affiliates or their respective directors, officers and employees will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
The information is current only as of its date and shall not, under any circumstances, create any implication that the information contained therein is correct as of any time subsequent to the date thereof or that there has been no change in the financial condition or affairs of the Company since such date. This document may be updated from time to time and there is no undertaking the Company or any of their affiliates to post any such amendments or supplements on this website
Failure to comply with this disclaimer may result in a violation of the applicable laws of India and other jurisdictions. Any other information contained in, or that can be accessed via our website does not constitute a part of the DRHP or the IPO AV.
IF YOU ARE NOT PERMITTED TO VIEW THE MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.
The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in any jurisdiction, including without limitation, India.
To access this information, you must confirm, by pressing on the button marked “I Confirm”, that at the time of access, you are located in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.
DISCLAIMER – IMPORTANT
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.
The following disclaimer applies to the Draft Red Herring Prospectus of Sahajanand Medical Technologies Limited (the “Company”) dated July 25, 2025 (“DRHP”) filed with the Securities and Exchange Board of India (the “SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) as well as the audio visual film of the Company (“IPO AV”), hosted on this website, in connection with the initial public offering of equity shares of face value ₹1 each of the Company (“Equity Shares” and such initial public offering as the “Offer”).
The DRHP has been made available on this website in electronic form solely to comply with Regulation 26 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the DRHP. The IPO AV is being made available on this website in accordance with SEBI master circular no. SEBI/HO/CFD/POD-1/P/CIR/2024/0154 dated November 11, 2024, issued by SEBI. By accessing the DRHP and/or the IPO AV, you agree to follow and be bound by the following terms and conditions, including any modifications to them from time to time. You should read the DRHP and seek professional advice before taking any action.
The DRHP and the IPO AV are directed at, and is intended for distribution to, and use by, residents of India only. The information in this portion of our website, including the DRHP and the IPO AV, is not intended for, and may not be accessed in or by, or distributed or transmitted in, into or to, directly or indirectly, the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”) or any other jurisdiction where it is unlawful to do so. All persons residing outside of the United States who wish to access the DRHP and/or the IPO AV contained on the following page of this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website or require registration or approval for any acquisition of securities by them. No part of the contents of the DRHP and the IPO AV shall be copied or duplicated in any form by any means or redistributed. Neither the DRHP nor the IPO AV amount to, or is intended to be, a prospectus or an offer document, in terms of the Companies Act, 2013, and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and nothing in the DRHP or the IPO AV constitutes an offer or an invitation by or on behalf of either the Company or any of the members of the Syndicate (as defined in the DRHP) to subscribe for or purchase any of the securities described therein.
The DRHP and the IPO AV do not constitute an offer to sell or an invitation to subscribe to the securities offered in any jurisdiction to any person to whom it is unlawful to make an offer or invitation in such jurisdiction and is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would be contrary to law or regulation; or (b) the Company or any of its affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements. The securities offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. Accordingly, the securities are only being offered and sold outside the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur.
The Company, and Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited (collectively, the “Book Running Lead Managers”) and their respective affiliates, directors, officers, agents, representatives, advisers and employees do not accept any liability whatsoever, direct or indirect, that may arise from the use of the information contained on this website. The information in the DRHP and the IPO AV is as of the date thereof and neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees are under any obligation to update or revise the DRHP and the IPO AV to reflect circumstances arising after the date thereof. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently, neither the Company, the Book Running Lead Managers nor any of their respective affiliates, directors, officers, agents, representatives, advisers or employees accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of the DRHP and the IPO AV in electronic format.
Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risks, see the section titled “Risk Factors” in the red herring prospectus which will be available when filed with the Registrar of Companies, Gujarat at Ahmedabad (“RoC”) and SEBI in the future. Any decision on whether to invest in the equity shares described in the DRHP and the IPO AV may only be made after a red herring prospectus has been filed with the RoC and must be made solely on the basis of the red herring prospectus proposed to be filed with the RoC. Potential investors should not rely on the DRHP filed with SEBI and the Stock Exchanges or on the IPO AV.
Any person into whose possession the Draft Red Herring Prospectus and the IPO AV comes is required to inform himself or herself about and to observe any restrictions. Investors are advised not to rely on any other document, content or information provided on the Offer on the internet / online websites/ social media platforms / micro-blogging platforms and by the influencers since the same is not approved/ commissioned/ paid by the Company or its promoter(s)/directors/KMPs in any manner. Investors are advised to rely only on the information contained in the Red Herring Prospectus and the price band advertisement for making investment decision.
You are accessing this website at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses. The Company and the Book Running Lead Managers cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the DRHP or the IPO AV beyond the date of the DRHP. Neither the Company, the Book Running Lead Managers nor their respective affiliates, directors, officers, agents, representatives, advisers or employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website, or by the use of this website, IPO AV or the DRHP. Neither the Company nor any of its affiliates or their respective directors, officers and employees will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
The information is current only as of its date and shall not, under any circumstances, create any implication that the information contained therein is correct as of any time subsequent to the date thereof or that there has been no change in the financial condition or affairs of the Company since such date. This document may be updated from time to time and there is no undertaking the Company or any of their affiliates to post any such amendments or supplements on this website
Failure to comply with this disclaimer may result in a violation of the applicable laws of India and other jurisdictions. Any other information contained in, or that can be accessed via our website does not constitute a part of the DRHP or the IPO AV.
IF YOU ARE NOT PERMITTED TO VIEW THE MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.
The documentation contained in these pages is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in any jurisdiction, including without limitation, India.
To access this information, you must confirm, by pressing on the button marked “I Confirm”, that at the time of access, you are located in India. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.
DISCLAIMER – IMPORTANT
PLEASE READ THIS NOTICE CAREFULLY - IT APPLIES TO ALL PERSONS WHO VIEW THIS SITE
NOT FOR ACCESS IN OR BY, OR DISTRIBUTION OR TRANSMISSION IN, INTO OR TO, DIRECTLY OR INDIRECTLY, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS), ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA (THE “UNITED STATES”) OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA.
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
The following disclaimer applies to the audio visual film (the “IPO AV”) of Sahajanand Medical Technologies Limited (the “Company”), in relation to the initial public offering of the equity shares of face value of ₹1 each (“Equity Shares”) of the Company (“Offer”). THE IPO AV IS BEING MADE AVAILABLE ON THIS WEBSITE IN ACCORDANCE WITH SEBI MASTER CIRCULAR NO. HO/49/14/14(2)2026-CFD-POD2/I/4518/2026 DATED FEBRUARY 09, 2026, ISSUED BY THE SECURITIES AND EXCHANGE BOARD OF INDIA. The Company is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to undertake an initial public offering of its Equity Shares (“Offer”) and has filed the red herring prospectus dated October 9, 2026 (“RHP” or “Red Herring Prospectus”) with the Registrar of Companies, Gujarat at Ahmedabad (“RoC”) and thereafter, submitted to the Securities and Exchange Board of India (“SEBI”) and BSE Limited and National Stock Exchange of India Limited (“Stock Exchanges”) and hosted on this website. The RHP is available on the website of SEBI at www.sebi.gov.in, and is available on the websites of the Stock Exchanges i.e. BSE and NSE at www.bseindia.com and www.nseindia.com, respectively, on the website of the Company at www.smtpl.com and the websites of the BRLMs, i.e., Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited at www.motilaloswal.com, www.avendus.com, www.business.hsbc.co.in and www.nuvama.com, respectively.
You are advised to read this disclaimer carefully before reading, accessing or making any other use of the IPO AV. By accessing the IPO AV, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.
This IPO AV provides only the salient features of the Offer and accordingly, potential investors should not rely on this video. Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the RHP, including the section titled “Risk Factors”. Any decision on whether to invest in the equity shares described in the RHP must be made solely on the basis of the RHP. As there may be material changes in the draft red herring prospectus dated July 25, 2025 (“DRHP”) versus the RHP, potential investors should not rely on the DRHP. The Company and BRLMs i.e., Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited and their respective affiliates, directors, officers, agents, representatives, advisers and employees do not accept any liability whatsoever, direct or indirect, that may arise from the use of the information contained in this video. Investors are advised not to rely on any other document, content or information provided in respect to the public issue on the internet/ online websites/ social media platforms/ micro-blogging platforms and by influencers/finfluencers since the same is not authorized/ approved/ commissioned/ paid by the Company or its Promoter/Directors/KMPs or SMPs in any manner. Any such posts, including on social media platforms, may be illegal in certain jurisdictions and only certain categories of persons may be authorized to access such information. Such posts, including on social media platforms, do not constitute an offer or solicitation of an offer, or any advice or recommendation to purchase, sell or transact in any of the Company’s securities. Investors are advised to rely only on the information contained in the RHP and pre-Offer and price band advertisement for making an investment decision. The information in the RHP is as of the date thereof and neither the Company, the BRLMs nor their respective affiliates, directors, officers, agents, representatives, advisers or employees are under any obligation to update or revise the RHP to reflect circumstances arising after the date thereof.
The IPO AV is directed at, and is intended for distribution to, and use by, residents of India only. Residents of countries other than India are not authorized to view or use the information in this portion of our website. The information in this portion of our website, including the IPO AV, is not for publication or distribution, directly or indirectly, in or into the United States. Please note that because of restrictions imposed by law on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. The contents of the IPO AV are for your information only and you acknowledge that access to the IPO AV is intended for use by you only and you agree not to forward the IPO AV on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents of the IPO AV shall be copied or duplicated in any form by any means, or redistributed.
This IPO AV is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format including the IPO AV does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India. Any other information contained in, or that can be accessed via our website does not constitute a part of this video.
This video is not intended for, and may not be accessed in or by, or distributed or transmitted in, into or to, directly or indirectly, the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”) or any other jurisdiction where it is unlawful to do so. All persons residing outside of the United States who wish to access this video should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this video or require registration or approval for any acquisition of securities by them. No part of the contents of this video shall be copied or duplicated in any form by any means or redistributed. This IPO AV is posted solely to comply with Indian legal and regulatory requirements. The IPO AV does not constitute an offer to sell, or the solicitation of an offer to purchase or acquire, any securities of the Company in the United States or in any other jurisdiction in which such offer or solicitation would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. The securities offered in the Offer have not been and will not be registered under the United States Securities Act of 1933 (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold outside of the United States to investors in offshore transactions as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur. No public offering of the Equity Shares or other securities is being made in the United States.
The Company has taken all necessary steps to ensure that the contents of the IPO AV as appearing on this website are consistent with the RHP filed with RoC, SEBI and the relevant regulatory authorities in India. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither the Company nor any of its affiliates, or their respective directors, officers. agents, representatives, advisers and employees (together, the “Affiliates”), accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of IPO AV in electronic format.
Any person into whose possession the IPO AV comes is required to inform himself or herself about and to observe any such restrictions. Neither the Company nor any of its Affiliates is soliciting any action based on any information contained on this website, including the IPO AV, and such information should not be construed as an offer to sell or the solicitation of an offer to buy or subscribe for any securities.
You are accessing this website at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses. Neither the Company nor any of its Affiliates will be liable or responsible for any kind of loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. Neither the Company nor any of its Affiliates represents that the content of the IPO AV is accurate or complete. The Company and its Affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the IPO AV beyond the date of the Red Herring Prospectus.
The Company and its Affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, nor any of its Affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, or inability to access or use of, the website or these materials or the IPO AV. Failure to comply with this disclaimer may result in a violation of the applicable laws of India and other jurisdictions.
IF YOU ARE NOT PERMITTED TO VIEW MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.
Please note that forms downloaded and used for subscription to the Offer in contravention of the above will be rejected with no recourse to the Company, the BRLMs or any of their respective Affiliates.
DISCLAIMER – IMPORTANT
PLEASE READ THIS NOTICE CAREFULLY - IT APPLIES TO ALL PERSONS WHO VIEW THIS SITE
NOT FOR ACCESS IN OR BY, OR DISTRIBUTION OR TRANSMISSION IN, INTO OR TO, DIRECTLY OR INDIRECTLY, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS), ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA (THE “UNITED STATES”) OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA.
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
The following disclaimer applies to the audio visual film (the “IPO AV”) of Sahajanand Medical Technologies Limited (the “Company”), in relation to the initial public offering of the equity shares of face value of ₹1 each (“Equity Shares”) of the Company (“Offer”). THE IPO AV IS BEING MADE AVAILABLE ON THIS WEBSITE IN ACCORDANCE WITH SEBI MASTER CIRCULAR NO. HO/49/14/14(2)2026-CFD-POD2/I/4518/2026 DATED FEBRUARY 09, 2026, ISSUED BY THE SECURITIES AND EXCHANGE BOARD OF INDIA. The Company is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to undertake an initial public offering of its Equity Shares (“Offer”) and has filed the red herring prospectus dated October 9, 2026 (“RHP” or “Red Herring Prospectus”) with the Registrar of Companies, Gujarat at Ahmedabad (“RoC”) and thereafter, submitted to the Securities and Exchange Board of India (“SEBI”) and BSE Limited and National Stock Exchange of India Limited (“Stock Exchanges”) and hosted on this website. The RHP is available on the website of SEBI at www.sebi.gov.in, and is available on the websites of the Stock Exchanges i.e. BSE and NSE at www.bseindia.com and www.nseindia.com, respectively, on the website of the Company at www.smtpl.com and the websites of the BRLMs, i.e., Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited at www.motilaloswal.com, www.avendus.com, www.business.hsbc.co.in and www.nuvama.com, respectively.
You are advised to read this disclaimer carefully before reading, accessing or making any other use of the IPO AV. By accessing the IPO AV, you agree to be bound by the following terms and conditions, including any modifications to them from time to time.
This IPO AV provides only the salient features of the Offer and accordingly, potential investors should not rely on this video. Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the RHP, including the section titled “Risk Factors”. Any decision on whether to invest in the equity shares described in the RHP must be made solely on the basis of the RHP. As there may be material changes in the draft red herring prospectus dated July 25, 2025 (“DRHP”) versus the RHP, potential investors should not rely on the DRHP. The Company and BRLMs i.e., Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited and their respective affiliates, directors, officers, agents, representatives, advisers and employees do not accept any liability whatsoever, direct or indirect, that may arise from the use of the information contained in this video. Investors are advised not to rely on any other document, content or information provided in respect to the public issue on the internet/ online websites/ social media platforms/ micro-blogging platforms and by influencers/finfluencers since the same is not authorized/ approved/ commissioned/ paid by the Company or its Promoter/Directors/KMPs or SMPs in any manner. Any such posts, including on social media platforms, may be illegal in certain jurisdictions and only certain categories of persons may be authorized to access such information. Such posts, including on social media platforms, do not constitute an offer or solicitation of an offer, or any advice or recommendation to purchase, sell or transact in any of the Company’s securities. Investors are advised to rely only on the information contained in the RHP and pre-Offer and price band advertisement for making an investment decision. The information in the RHP is as of the date thereof and neither the Company, the BRLMs nor their respective affiliates, directors, officers, agents, representatives, advisers or employees are under any obligation to update or revise the RHP to reflect circumstances arising after the date thereof.
The IPO AV is directed at, and is intended for distribution to, and use by, residents of India only. Residents of countries other than India are not authorized to view or use the information in this portion of our website. The information in this portion of our website, including the IPO AV, is not for publication or distribution, directly or indirectly, in or into the United States. Please note that because of restrictions imposed by law on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. The contents of the IPO AV are for your information only and you acknowledge that access to the IPO AV is intended for use by you only and you agree not to forward the IPO AV on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents of the IPO AV shall be copied or duplicated in any form by any means, or redistributed.
This IPO AV is posted solely to comply with Indian legal and regulatory requirements. Making the information contained herein available in electronic format including the IPO AV does not constitute an offer to sell, the solicitation of an offer to buy, or a recommendation to buy or sell securities of the Company in the United States or in any other jurisdiction, including without limitation, India. Any other information contained in, or that can be accessed via our website does not constitute a part of this video.
This video is not intended for, and may not be accessed in or by, or distributed or transmitted in, into or to, directly or indirectly, the United States of America (including its territories and possessions), any state of the United States and the District of Columbia (the “United States”) or any other jurisdiction where it is unlawful to do so. All persons residing outside of the United States who wish to access this video should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this video or require registration or approval for any acquisition of securities by them. No part of the contents of this video shall be copied or duplicated in any form by any means or redistributed. This IPO AV is posted solely to comply with Indian legal and regulatory requirements. The IPO AV does not constitute an offer to sell, or the solicitation of an offer to purchase or acquire, any securities of the Company in the United States or in any other jurisdiction in which such offer or solicitation would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. The securities offered in the Offer have not been and will not be registered under the United States Securities Act of 1933 (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold outside of the United States to investors in offshore transactions as defined in and in compliance with Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur. No public offering of the Equity Shares or other securities is being made in the United States.
The Company has taken all necessary steps to ensure that the contents of the IPO AV as appearing on this website are consistent with the RHP filed with RoC, SEBI and the relevant regulatory authorities in India. You are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither the Company nor any of its affiliates, or their respective directors, officers. agents, representatives, advisers and employees (together, the “Affiliates”), accepts any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of IPO AV in electronic format.
Any person into whose possession the IPO AV comes is required to inform himself or herself about and to observe any such restrictions. Neither the Company nor any of its Affiliates is soliciting any action based on any information contained on this website, including the IPO AV, and such information should not be construed as an offer to sell or the solicitation of an offer to buy or subscribe for any securities.
You are accessing this website at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses. Neither the Company nor any of its Affiliates will be liable or responsible for any kind of loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website. Neither the Company nor any of its Affiliates represents that the content of the IPO AV is accurate or complete. The Company and its Affiliates cannot and do not guarantee the accuracy, timeliness or completeness of the information being made available to you in the IPO AV beyond the date of the Red Herring Prospectus.
The Company and its Affiliates will not be responsible for any loss to any person or entity caused by any shortcoming, defect or inaccuracy which may have inadvertently or otherwise crept into the website. Neither the Company, nor any of its Affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, or inability to access or use of, the website or these materials or the IPO AV. Failure to comply with this disclaimer may result in a violation of the applicable laws of India and other jurisdictions.
IF YOU ARE NOT PERMITTED TO VIEW MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.
Please note that forms downloaded and used for subscription to the Offer in contravention of the above will be rejected with no recourse to the Company, the BRLMs or any of their respective Affiliates.